RxDoctor Payments DataLook up a doctor →

Nathan Averill, MD

Family Medicine · Moncks Corner, SCNPI 1891824355

Payments from drug & device makers

$25,451in general payments, 2019–2025

Across 1,012 payments — averaging $25.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$12K
  • Novo Nordisk$1K
  • AstraZeneca$1K
  • Lilly USA, LLC$1K
  • GSK$950
  • Pfizer$791
  • plus $8K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)269$11,929
Novo Nordisk82$1,226
AstraZeneca(2 entities)62$1,213
Lilly USA, LLC70$1,136
GSK58$950
Pfizer50$791
Otsuka America Pharmaceutical, Inc.31$613
Sanofi-aventis U.S. LLC19$532
Amgen(2 entities)28$472
Novartis26$455
Insulet Corporation18$396
Bayer22$387
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)16$343
Corium, LLC14$325
Axsome Therapeutics, Inc.14$321
Xeris Pharmaceuticals, Inc.17$321
Takeda Pharmaceuticals U.S.A., Inc.17$320
Abbott13$293
Johnson & Johnson20$288
Dexcom, Inc.6$186
Upsher-smith Laboratories LLC10$182
Sunovion Pharmaceuticals Inc.9$181
Boehringer Ingelheim10$176
Merck12$168
Exact Sciences9$165
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC9$133
Vanda Pharmaceuticals Inc.4$112
Astellas Pharma US Inc5$109
Esperion Therapeutics, Inc.7$108
Nestle Healthcare Nutrition Inc.5$97
Boston Scientific3$96
Cequr Corporation3$95
Supernus Pharmaceuticals, Inc.4$95
Corcept Therapeutics4$92
Antares Pharma, Inc.5$91
Eisai Inc.6$87
Idorsia Pharmaceuticals US Inc5$84
Seqirus USA Inc3$68
Amneal Pharmaceuticals LLC3$63
Jazz Pharmaceuticals Inc.3$61
Biohaven Pharmaceuticals, Inc.4$59
Lundbeck LLC2$57
Shire North American Group Inc4$54
Endo Pharmaceuticals Inc.4$53
Biohaven Pharmaceutical Holding Company Ltd.2$48
Amarin Pharma, Inc.3$46
Ultragenyx Pharmaceutical Inc.2$41
Tris Pharma Inc2$41
Teva Pharmaceuticals USA, Inc.3$40
Ironwood Pharmaceuticals, Inc2$32
Ascendis Pharma Endocrinology Inc1$25
Edwards Lifesciences1$22
Therapeuticsmd, Inc.1$19
Nevro Corp.1$19
Ironshore Pharmaceuticals Inc.1$17
Philips North America LLC1$16
Alfasigma USA, Inc.1$16
Tolmar, Inc.1$16
Arbor Pharmaceuticals, Inc.1$16
Medtronic1$15

How this compares

$25,451 in reported general payments places this provider in the 95th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina →

Medicare billing

Part B allowed, 2024
$205,041
Medicare patients
320
Services billed
5,281

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Moncks Corner

See the full list for South Carolina →

Where these figures come from

Is this you, or does something look wrong? →